Enterprise Value
79.34M
Cash
214.6M
Avg Qtr Burn
-1.758M
Short % of Float
6.96%
Insider Ownership
28.26%
Institutional Own.
52.32%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
P-BCMA-ALLO1 (CAR-T) Details Multiple myeloma, Cancer | Phase 1/2 Data readout | |
P-MUC1C-ALLO1 Details Cancer, Ovarian cancer, Solid tumor/s, Breast cancer | Phase 1 Data readout | |
P-CD19CD20-ALLO1 Details Cancer, B-cell malignancies | Phase 1 Initiation | |
P-PSMA-101 (CAR-T) Details Prostate cancer, Castration-resistant prostate cancer, Cancer | Failed Discontinued |